Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts.

Autor: Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix-Marseille University, APHM, Marseille, France., Grob JJ; Dermatology and Skin Cancer Department, Aix-Marseille University, APHM, Marseille, France., Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Ascierto PA; Department of Skin Cancer, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Arron S; Peninsula Dermatology, Burlingame, California, USA., Basset-Seguin N; Dermatology Department, Saint-Louis Hospital, Paris, France., Bohne AS; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany., Lenoir C; Department of Dermatology, Hôpitaux Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Dummer R; Skin Cancer Centre at University Hospital Zurich, Zurich, Switzerland., Fargnoli MC; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Guminski A; Department of Medical Oncology, Royan North Shore Hospital, Sydney, New South Wales, Australia.; Northern Clinical School, University of Sydney, Sydney, New South Wales, Australia., Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany., Kaufmann R; Department of Dermatology, Venereology and Allergology, Frankfurt University Hospital, Frankfurt, Germany., Lallas A; First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece., Del Marmol V; Department of Dermatology, University Hospital Erasme, Universite'Libre de Bruxelles, Brussels, Belgium., Migden M; Departments of Dermatology and Head and Neck Surgery, UT MD Anderson Cancer Center, Houston, Texas, USA., Penicaud M; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, APHM, La Conception University Hospital, Marseille, France., Rembielak A; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Stratigos A; 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tagliaferri L; Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy., Zalaudek I; Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy., Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clínic, Barcelona, Spain., Badinand D; Department of Radiotherapy Oncology, Hospital La Timone, Marseille, France., Bossi P; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Milan, Italy., Challapalli A; Department of Oncology, Bristol Haematology and Oncology Centre, UHBW, Bristol, UK., Clementi M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Di Stefani A; UOC Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Ferrándiz-Pulido C; Department of Dermatology, University Hospital Vall d'Hebron, Barcelona, Spain.; Facultad de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain., Giuffrida R; Department of Clinical and Experimental Medicine, Dermatology - University of Messina, Messina, Italy., Gravina GL; Department of Biotechnological and Applied Clinical Sciences, Radiotherapy and Radiobiology Unit, University of L'Aquila, L'Aquila, Italy., Ha P; Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Heinzerling L; Department of Dermatology and Allergy, Ludwig-Maximilian University Hospital, LMU, Munich, Germany., Mallet S; Dermatology and Skin Cancer Department, Aix-Marseille University, APHM, Marseille, France., Paradisi A; UOC Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Mohr P; Department of Dermatology, Elbe-Kliniken Buxtehude, Buxtehude, Germany., Piccerillo A; UOC Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Rutkowski D; Department of Dermatology, Manchester Foundation Trust, Manchester, UK., Saiag P; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, APHP, & EA 4340 'Biomarkers in Cancerology and Hemato-Oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France., Sollena P; UOC Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Trakatelli M; Second Department of Dermatology, Aristotle University Medical School, Papageorgiou General Hospital, Thessaloniki, Greece., Wojcieszek P; Brachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO), Gliwice, Poland., Yom SS; Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA., Zelin E; Institute of Dermatology, Santa Maria Della Misericordia University Hospital, Udine, Italy., Peris K; UOC Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Malvehy J; Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona and CIBER de enfermedades Raras, ICIII, Barcelona, Spain.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jul 03. Date of Electronic Publication: 2024 Jul 03.

Penoscrotal Paget's disease

Autor: Dauendorffer, J.-N., Herms, F., Baroudjian, B., Basset-Seguin, N., Cavelier-Balloy, B., Fouéré, S., Bagot, M., Lebbé, C.

Publikováno v: In Annales de Dermatologie et de Vénéréologie June 2021 148(2):71-76

Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high-throughput sequencing approach.

Autor: Louveau B; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Nakouri I; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Jouenne F; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Baroudjian B; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Sadoux A; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Da Meda L; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Osio A; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; CND-Paris la Roquette, Ivry, France.; French Network of Rare Skin Cancers, CARADERM, France., Reinhart F; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Robert J; DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Herms F; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Cribier B; French Network of Rare Skin Cancers, CARADERM, France.; Dermatology and Dermatopathology, Faculty of Medicine, University Hospital, University of Strasbourg, Strasbourg, France., Mortier L; French Network of Rare Skin Cancers, CARADERM, France.; Department of Dermatology, Claude Huriez Hospital and University of Lille, Lille, France., Jouary T; French Network of Rare Skin Cancers, CARADERM, France.; Department of Dermatology, Hospital Center of Pau, Pau, France., Basset Seguin N; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Lebbé C; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mourah S; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Battistella M; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; French Network of Rare Skin Cancers, CARADERM, France.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Sep 18; Vol. 191 (4), pp. 639-641.

A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.

Autor: Hughes BGM; Department of Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: brett.hughes@health.qld.gov.au., Guminski A; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Bowyer S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia., Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, California., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Lewis KD; University of Colorado Denver Cancer Center, Aurora, Colorado., Ansstas G; Department of Surgical Oncology, Washington University School of Medicine, St Louis, Missouri., Day F; Department of Medical Oncology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia., Ladwa R; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Stein BN; Adelaide Cancer Centre, Adelaide, South Australia, Australia., Muñoz Couselo E; Department of Medical Oncology, Melanoma and Other Skin Tumors Unit, Vall d'Hebron University Hospital, Barcelona, Spain., Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany., Hauschild A; Department of Dermatology, University Hospital (UKSH), Kiel, Germany., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, NCT-West, Campus Essen and University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Basset-Seguin N; Hôpital Saint-Louis, Paris, France., Modi B; Division of Dermatology, Department of Surgery, City of Hope, Duarte, California., Dalac-Rat S; Hospital Center University Dijon Bourgogne, Dijon, France., Dunn LA; David H. Koch Center for Cancer Care, Memorial Sloan Kettering Cancer Center, New York, New York., Flatz L; University Hospital Tübingen, Tübingen, Germany., Mortier L; Centre Hospitalier Régional Universitaire de Lille (CHRU), Lille, France., Guégan S; Department of Dermatology, Hôpital Cochin, Paris, France., Heinzerling LM; Department of Dermatology, LMU University Hospital Munich, Munich, Germany; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany., Mehnert JM; Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health, New York, New York., Trabelsi S; CHU de Grenoble - Hôpital A Michallon, Grenoble, France., Soria-Rivas A; Ramón y Cajal University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain., Stratigos AJ; First Department of Dermatology-Venereology, Andreas Sygros Hospital, Athens, Greece; National and Kapodistrian University of Athens Medical School, Athens, Greece., Ulrich C; Charite-Universitatsmedizin Berlin, Berlin, Germany., Wong DJ; UCLA Department of Medicine, Los Angeles, California., Beylot-Barry M; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Bossi P; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy., Bugés Sánchez C; Department of Medical Oncology, Skin Tumors Unit, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Barcelona, Spain; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Barcelona, Spain., Chandra S; Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Robert C; Gustave Roussy Cancer Center, Villejuif, France., Russell JS; Head and Neck/Cutaneous Medical Oncology, Huntsman Cancer Institute, Salt Lake City, Utah., Silk AW; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Booth J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yoo SY; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep 07. Date of Electronic Publication: 2024 Sep 07.

Traitement médical des carcinomes basocellulaires avancés

Autor: Basset-Seguin, N.

Publikováno v: In Annales de Dermatologie et de Vénéréologie November 2018 145 Supplement 5:S36-S41